Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status"

Article metrics

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    LaFave, L.M. et al. Nat. Med. 21, 1344–1349 (2015).

  2. 2

    Schoumacher, M. et al. Nat. Med. 22, 577–578 (2016).

  3. 3

    Kim, K.H. & Roberts, C.W. Nat. Med. 22, 128–134 (2016).

  4. 4

    Fong, C.Y. et al. Nature 525, 538–542 (2015).

  5. 5

    Matatall, K.A. et al. BMC Cancer 13, 371 (2013).

  6. 6

    Harbour, J.W. et al. Science 330, 1410–1413 (2010).

  7. 7

    Campbell, J.E. et al. ACS Med. Chem. Lett. 6, 491–495 (2015).

  8. 8

    Kim, K.H. et al. Nat. Med. 21, 1491–1496 (2015).

Download references

Author information

Correspondence to Ross L Levine.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Further reading